Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 1 - 20
of 215
Sorted by Relevance
|
Sort by Date
8 Mar 2012, 6:44 pm
Longoria, Merrell Dow Pharmaceuticals, Inc. v. [read post]
31 Oct 2016, 7:18 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the United States Supreme Court replaced the old Frye test for determining the admissibility of expert evidence with the new Daubert, pursuant to which judges serve as gatekeepers and... [read post]
28 Dec 2018, 2:22 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), appealed a Ninth Circuit ruling that the Frye rule survived, and was incorporated into, the enactment of a statutory evidentiary rule, Rule 702. [read post]
5 Apr 2017, 3:00 am
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993). [read post]
8 Jul 2011, 8:52 am
MERRELL DOW PHARMACEUTICALS, INC., laying down the foundation of admissibility of scientific expert testimony. [read post]
17 Nov 2018, 12:10 pm
To be sure, judges have often poorly expressed their reasoning for deciding scientific evidentiary issues, and perhaps poor communication or laziness by judges was responsible for Rothman’s interest in joining the Daubert fray. [read post]
20 Aug 2014, 7:12 pm
AstenJohnson, Inc. 13-1252 Issue: Whether, in a federal jury case, a district judge’s procedural failure to make detailed findings under Daubert v. [read post]
26 Apr 2007, 3:08 pm
Merrell Dow Pharmaceuticals, Inc., 509 U. [read post]
1 Dec 2010, 11:02 am
Merrell Dow Pharmaceuticals set the standard regarding the admissibility of expert witness testimony in federal court. [read post]
18 Feb 2009, 12:01 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 589 (1993) Can the Daubert requirement be fulfilled during the trial? [read post]
21 Feb 2009, 11:41 am
Merrel Dow Pharmaceuticals and Kumho Tire Inc. v. [read post]
25 Oct 2011, 9:05 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 595 (1993), that “[e]xpert evidence can be both powerful and quite misleading because of the difficulty in evaluating it. [read post]
22 Oct 2015, 1:29 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), you must object to an expert, such as a doctor, when his testimony does not comply with Fla. [read post]
2 Jul 2013, 6:17 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
22 May 2009, 8:53 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
24 Mar 2009, 11:54 am
Merrell Dow Pharmaceuticals was a U.S. [read post]
13 Apr 2009, 1:01 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
16 Oct 2014, 7:10 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and Rule 702, Fed. [read post]
1 Nov 2016, 8:27 pm
Merrell Dow Pharmaceuticals must be satisfied for a class to be certified under Federal Rule of Civil Procedure 23 when challenged expert testimony is at issue, particularly in light of this court leaving issues open in Tyson Foods, Inc. v. [read post]
26 Feb 2017, 7:10 am
Merrell Dow Pharmaceuticals, Inc.). [read post]
